Its knockdown drives HDAC2 translocation to the nucleoplasm, increasing occupancy on VHL and VDAC1 promoters, thereby enhancing glycolysis and glutaminolysis to support tumor survival and growth (Fig. 6E) [96]. The gene discussed is VHL; the disease is neoplasm.